Inhibitory effects of hypercholesterolemia and Ox-LDL on angiogenesis- like endothelial growth in rabbit aortic explants: Essential role of basic fibroblast growth factor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 7, 1997, Pages 1303-1312

  Chen, Chu Huang ^a   Cartwright Jr , Joiner ^a   Li, Zheng ^a   Lou, Sherry ^a   Nguyen, Hai Hoang ^a   Gotto Jr , Antonio M ^a   Henry, Philip D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Hypercholesterolemia; Oxidized LDL

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; LOW DENSITY LIPOPROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL GROWTH; DNA SYNTHESIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FOAM CELL; HYPERCHOLESTEROLEMIA; INFLAMMATORY CELL; MALE; MICROTUBULE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RABBIT;

EID: 0030836338     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.7.1303     Document Type: Article

References (17)

1. Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation. 1992;85:1197-1204.
2. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R, and the TIMI Investigators. Influence of coronary collateral vessels on myocardial infarct size in humans. Circulation. 1991;83:739-746.
3. Gregg DE. The natural history of coronary 'collateral' development. Circ Res. 1974;35:335-344.
4. Schaper W. Coronary collateral development: concepts and hypothesis. In: Schaper W, Schaper J, eds. Collateral Circulation. Norwell, Mass: Kluwer Academic Publishers; 1993:41-64.
5. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedman P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181-191.
6. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
7. Takeshita S, Kearney M, Loushin C, Brogi E, Zheng LP, Horowitz J, Ferrara N, Symes JF, Isner JM. In vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb. J Clin Invest. 1994;93:662-670.
8. Henry PD. Hypercholesterolemia and angiogenesis. Am J Cardiol. 1993;72(suppl):61C-64C.
9. Chen CH, Nguyen HH, Weilbaecher D, Luo S, Gotto AM Jr, Henry PD. Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro. Atherosclerosis. 1995;116:261-268.
10. Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310:175-177.
11. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest. 1993;92:2408-2418.
12. Sunderkoetter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol. 1994;55:410-422.
13. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
14. Henriksen T, Evensen SA, Carlander B. Injury to cultured endothelial cells induced by low density lipoproteins: protection by high density lipoproteins. Scand J Clin Lab Invest. 1979;39:369-375.
15. Hessler JR, Robertson AL Jr, Chisolm GM III. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979;32:213-229.
16. Kugiyama K, Kerns S, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dcpendent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
17. Mangin E Jr, Kugiyama K, Nguy J, Kerns S, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 1993;72:-161-166.